http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100351629-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14 |
| filingDate | 2000-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2002-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100351629-B1 |
| titleOfInvention | 5-(4-Substituted-[1,2,5]thiadiazol-3-yl)-3-methyl-1,2,3,4-tetrahydropyrimidine derivatives and process for preparing them |
| abstract | The present invention is a 5- (4-substituted- [1,2,5] -thiadiazole-3- represented by the following formula (1), which is useful as a muscarinic receptor agonist and a therapeutic agent for memory hypersensitivity and senile dementia. (1) -3-methyl-1,2,3,4-tetrahydropyrimidine derivatives, pharmaceutically acceptable salts thereof, methods for their preparation, and uses thereof.n n n n n n n n n n In Formula 1, X represents a dialkylamine group, a piperidinyl group, a pyrrolidinyl group, a morpholinyl group, or an N-methylpiperazinyl group. |
| priorityDate | 2000-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 64.